Studies on tuberactinomycin. 3. Isolation and characterization of two minor components, tuberactinomycin B and tuberactinomycin O. - Suppr | 超能文献

Studies on tuberactinomycin. 3. Isolation and characterization of two minor components, tuberactinomycin B and tuberactinomycin O.

作者信息

Izumi R, Noda T, Ando T, Take T, Nagata A

出版信息

J Antibiot (Tokyo). 1972 Apr;25(4):201-7.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Studies on tuberactinomycin. 3. Isolation and characterization of two minor components, tuberactinomycin B and tuberactinomycin O.

J Antibiot (Tokyo). 1972 Apr;25(4):201-7.

2

Studies on tuberactinomycin. II. Isolation and properties of tuberactinomycin-N, a new tuberactinomycin group antibiotic.结核放线菌素的研究。II. 结核放线菌素-N的分离与性质，一种新的结核放线菌素类抗生素。

J Antibiot (Tokyo). 1971 Oct;24(10):680-6.

3

Moenomycin. VII. Isolation and properties of further components of the antibiotic moenomycin.莫能菌素。VII. 抗生素莫能菌素其他组分的分离与特性

J Antibiot (Tokyo). 1969 Dec;22(12):597-602.

4

Studies on new antibiotic lividomycins. II. Isolation and characterization of lividomycins A, B and other aminoglycosidic antibiotics produced by Streptomyces lividus.新型抗生素青紫霉素的研究。II. 青紫霉素A、B及由青紫链霉菌产生的其他氨基糖苷类抗生素的分离与特性

J Antibiot (Tokyo). 1971 Jun;24(6):339-46.

5

Jokipeptin, a new peptide antibiotic. I. Isolation, physico-chemical and biological characteristics.乔基肽，一种新型肽类抗生素。I. 分离、理化及生物学特性

J Antibiot (Tokyo). 1972 May;25(5):304-8.

6

[Basic studies on viomycin and tuberactinomycin (author's transl)].

Kekkaku. 1975 Oct;50(10):295-301.

7

[The experimental studies on antituberculous activity of lividomycin].[青紫霉素抗结核活性的实验研究]

Kekkaku. 1972 May;47(5):135-8.

8

Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug.新型抗菌药物结核放线菌素的抗结核活性研究

Am Rev Respir Dis. 1969 Aug;100(2):228-30. doi: 10.1164/arrd.1969.100.2.228.

9

Studies on tuberactinomycin (tuberactin), a new antibiotic. I. Taxonomy of producing strain, isolation and characterization.

J Antibiot (Tokyo). 1968 Dec;21(12):681-7. doi: 10.7164/antibiotics.21.681.

10

A new peptide antibiotic complex S-520. I. Isolation and characterization.

J Antibiot (Tokyo). 1970 Sep;23(9):429-31. doi: 10.7164/antibiotics.23.429.

引用本文的文献

1

Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks.利用放线菌次生代谢产物进行结核病药物发现：历史趋势、现状与未来展望。

Nat Prod Bioprospect. 2025 Aug 11;15(1):52. doi: 10.1007/s13659-025-00533-8.

2

A biomimetic domino reaction for the concise synthesis of capreomycidine and epicapreomycidine.一种仿生级联反应用于简洁合成头孢霉烯和埃皮头孢霉烯。

Amino Acids. 2012 Dec;43(6):2313-28. doi: 10.1007/s00726-012-1309-8. Epub 2012 May 23.

3

Roles of VioG and VioQ in the incorporation and modification of the Capreomycidine residue in the peptide antibiotic viomycin.VioG和VioQ在肽抗生素紫霉素中Capreomycidine残基的掺入和修饰中的作用。

J Nat Prod. 2007 Apr;70(4):618-22. doi: 10.1021/np060605u. Epub 2007 Feb 16.